Serotonin Transporters in Obsessive-Compulsive-Related Disorders
Completed
Conditions studied: Obsessive-Compulsive Disorder
In brief
This study will compare serotonin transporters in patients with obsessive-compulsive disorder (OCD) and healthy volunteers in order to better understand the role of serotonin in OCD. Serotonin is a chemical in the brain that transmits nerve impulses. The serotonin transporter (SERT) is a protein that regulates serotonin levels in the brain. Normal, healthy volunteers and patients with OCD between 18 and 50 years of age and in overall good health may be eligible for this study. Candidates are screened with a medical history, physical examination, blood and urine tests, and a psychological interview and tests related to OCD symptoms. Participants undergo the following tests: * Positron emission tomography (PET) scanning: For this test, subjects lie on the scanner bed, wearing special masks that are fitted to their heads and attached to the beds to help keep their heads still during the procedure. An 8-minute "transmission" scan is done to provide measures of the brain that will help calculate information obtained from subsequent scans. Then, a radioactive tracer is injected into a catheter (plastic tube) placed in the arm. The scan produces images of the serotonin transporters in the brain. Pictures are taken for about 2 hours, while the subject lies still on the scanner bed. * Magnetic resonance imaging (MRI) scanning: An MRI scan of the brain is done within 1 year of the PET scan-that is, up to 1 year before or 1 year after the PET scan. MRI uses a magnetic field and radio waves to produce images of body tissues and organs. For this procedure, the patient lies on a table that is moved into the scanner (a narrow cylinder), wearing earplugs to muffle loud knocking and thumping sounds that occur during the scanning process. The procedure lasts about 1 hour, during which the patient will be asked to lie still for up to a few minutes at a time. * Genotyping: Subjects provide a blood sample (4 tablespoons) for DNA testing to look for genes or gene regions that may contribute to serotonin activity. This may lead to a better understanding of the genetic underpinnings of the serotonin system that influence mood, movement, and addiction.
Key facts
- Study ID
- NCT00082550
- Run by
- National Institute of Mental Health (NIMH)
- People needed
- 30
- Starts
- 2004-05-10
- Expected to finish
- 2007-04-09
- Last updated by the study team
- 2017-07-02
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may not qualify if…
- Healthy Subjects:
- History or current DSM-IV Axis I diagnostic criteria.
- Patients and Controls:
- Current diagnosis of major depressive disorder.
- Patients and Controls:
- Psychotropic medications, including SSRIs and antipsychotic medications. Drug free period must be greater than 4 weeks.
- Patients and Controls:
- Claustrophobia
- Patients and Controls:
- Pregnancy. Women with child bearing potential.
- Patients and Controls:
- Prior participation in other research protocols within the past year such that a radiation exposure together with the present study would exceed the annual limits.
- Patients and Controls:
- Any condition that increases risk for MRI (e.g., pacemaker, metallic foreign body in the eye, etc.)
Where it is running
- National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.